Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by toinv261on May 02, 2015 10:04am

143 Views

Post# 23687949

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:INTERESTING INFO FROM F6 ON THE OTHER BOARD/ THANKS F6

Hey DNDStocks. I'll guess you are on Georgian Bay or perhaps the other way towards Haliburton!

Have a great boating season. My positive bias says you'll be able to pay for your boat gas based on RVX performance and if you are a sailor, then all the better. I love sailing but only get the opportunity a couple of time a year.

Enjoy the weekend.
Cheers
Toinv :)

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?